232 related articles for article (PubMed ID: 22850406)
21. Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease.
Hwang JW; Yang HM; Lee H; Lee HK; Jeon YT; Kim JE; Lim YJ; Park HP
Br J Anaesth; 2013 May; 110(5):773-9. PubMed ID: 23274781
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative evaluation of local cerebral hemodynamic change by laser speckle contrast imaging for predicting postoperative cerebral hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease.
Tao T; Zhu W; Yu J; Li X; Wei W; Hu M; Luo M; Wan G; Li P; Chen J; Zhang J
J Cereb Blood Flow Metab; 2024 Jul; 44(7):1163-1173. PubMed ID: 38233750
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.
Fujimura M; Niizuma K; Endo H; Sato K; Inoue T; Shimizu H; Tominaga T
Neurol Res; 2015 Feb; 37(2):131-8. PubMed ID: 25082550
[TBL] [Abstract][Full Text] [Related]
24. Characteristic Pattern of the Cerebral Hemodynamic Changes in the Acute Stage After Combined Revascularization Surgery for Adult Moyamoya Disease: N-isopropyl-p-[
Fujimura M; Tominaga T
Acta Neurochir Suppl; 2021; 132():57-61. PubMed ID: 33973029
[TBL] [Abstract][Full Text] [Related]
25. Transient Symptomatic Downregulation of Cortical Neurotransmitter Receptor Function Due to Cerebral Hyperperfusion after Arterial Bypass Surgery for a Patient with Ischemic Moyamoya Disease.
Shimada Y; Kojima D; Yoshida J; Kobayashi M; Yoshida K; Fujiwara S; Ogasawara K
Neurol Med Chir (Tokyo); 2018 Nov; 58(11):481-484. PubMed ID: 30369534
[TBL] [Abstract][Full Text] [Related]
26. Measurement of Intraoperative Graft Flow Predicts Radiological Hyperperfusion during Bypass Surgery in Patients with Moyamoya Disease.
Nakamura A; Kawashima A; Nomura S; Kawamata T
Cerebrovasc Dis Extra; 2020; 10(2):66-75. PubMed ID: 32726777
[TBL] [Abstract][Full Text] [Related]
27. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'.
Tu XK; Fujimura M; Rashad S; Mugikura S; Sakata H; Niizuma K; Tominaga T
Neurosurg Rev; 2017 Jul; 40(3):507-512. PubMed ID: 28357585
[TBL] [Abstract][Full Text] [Related]
28. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
[TBL] [Abstract][Full Text] [Related]
29. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease.
Fujimura M; Niizuma K; Inoue T; Sato K; Endo H; Shimizu H; Tominaga T
Neurosurgery; 2014 Feb; 74(2):163-70; discussion 170. PubMed ID: 24176958
[TBL] [Abstract][Full Text] [Related]
30. Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease.
Uchino H; Kazumata K; Ito M; Nakayama N; Kuroda S; Houkin K
Neurosurg Rev; 2021 Feb; 44(1):599-605. PubMed ID: 32076897
[TBL] [Abstract][Full Text] [Related]
31. Transient Global Cerebral Hypoperfusion as a Characteristic Cerebral Hemodynamic Pattern in the Acute Stage after Combined Revascularization Surgery for Pediatric Moyamoya Disease: N-Isopropyl-P-[123I] Iodoamphetamine Single-Photon Emission Computed Tomography Study.
Kanoke A; Fujimura M; Tashiro R; Ozaki D; Tominaga T
Cerebrovasc Dis; 2022; 51(4):453-460. PubMed ID: 34933301
[TBL] [Abstract][Full Text] [Related]
32. Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients-case-control study.
Katsuki M; Fujimura M; Tashiro R; Tomata Y; Nishizawa T; Tominaga T
Neurosurg Rev; 2021 Aug; 44(4):2191-2200. PubMed ID: 32968846
[TBL] [Abstract][Full Text] [Related]
33. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease?
Mukerji N; Cook DJ; Steinberg GK
J Neurosurg; 2015 Jan; 122(1):90-4. PubMed ID: 25343178
[TBL] [Abstract][Full Text] [Related]
34. Preoperative central benzodiazepine receptor binding potential and cerebral blood flow images on SPECT predict development of new cerebral ischemic events and cerebral hyperperfusion after carotid endarterectomy.
Sato Y; Ogasawara K; Kuroda H; Suzuki T; Chida K; Fujiwara S; Aso K; Kobayashi M; Yoshida K; Terasaki K; Ogawa A
J Nucl Med; 2011 Sep; 52(9):1400-7. PubMed ID: 21795362
[TBL] [Abstract][Full Text] [Related]
35. Effect of Sevoflurane Postconditioning on the Incidence of Symptomatic Cerebral Hyperperfusion After Revascularization Surgery in Adult Patients with Moyamoya Disease.
Yoon HK; Oh H; Lee HC; Cho WS; Kim JE; Park JW; Choi H; Park HP
World Neurosurg; 2020 Feb; 134():e991-e1000. PubMed ID: 31734419
[TBL] [Abstract][Full Text] [Related]
36. Cerebral blood flow and oxygen metabolism measurements using positron emission tomography on the first day after carotid artery stenting.
Kawai N; Hatakeyama T; Okauchi M; Kawanishi M; Shindo A; Kudomi N; Yamamoto Y; Nishiyama Y; Tamiya T
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e55-64. PubMed ID: 24119366
[TBL] [Abstract][Full Text] [Related]
37. [Asymptomatic intracerebral hemorrhage under strict blood pressure control due to postoperative cerebral hyperperfusion in a patient with moyamoya disease].
Ito A; Fujimura M; Inoue T; Tominaga T
No Shinkei Geka; 2011 Jul; 39(7):681-6. PubMed ID: 21719912
[TBL] [Abstract][Full Text] [Related]
38. Preoperative platelet count may predict postoperative symptomatic cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis in moyamoya patients.
Jo WY; Oh H; Kim H; Yoon HK; Lee HC; Cho WS; Kim JE; Park HP
Clin Neurol Neurosurg; 2020 Dec; 199():106260. PubMed ID: 33031987
[TBL] [Abstract][Full Text] [Related]
39. Delayed development of cerebral atrophy after cerebral hyperperfusion following arterial bypass for adult patients with ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort.
Katakura Y; Kubo Y; Dobashi K; Kimura K; Fujiwara S; Chida K; Kobayashi M; Yoshida K; Terasaki K; Ogasawara K
Acta Neurochir (Wien); 2022 Apr; 164(4):1037-1045. PubMed ID: 35122551
[TBL] [Abstract][Full Text] [Related]
40. Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease.
Sugino T; Mikami T; Miyata K; Suzuki K; Houkin K; Mikuni N
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):811-6. PubMed ID: 22721824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
